Clinical Trials Browser

Phase 1/2 × enzastaurin × CNS × Clear all

NCT00402116 2020-08-06

Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients

Phase 1/2 Completed

72 enrolled 19 charts

Glioblastoma, Gliosarcoma